Form 8-K - Current report:
SEC Accession No. 0001641172-25-003711
Filing Date
2025-04-11
Accepted
2025-04-11 07:00:33
Documents
16
Period of Report
2025-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52156
2 ex10-1.htm EX-10.1 99424
3 ex10-2.htm EX-10.2 63415
4 ex10-3.htm EX-10.3 56201
  Complete submission text file 0001641172-25-003711.txt   488753

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xtnt-20250410.xsd EX-101.SCH 3027
6 XBRL LABEL FILE xtnt-20250410_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE xtnt-20250410_pre.xml EX-101.PRE 24173
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3580
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 25829829
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)